Edwards Lifesciences Corp. (EW)
102.14
+1.32
(+1.31%)
USD |
NYSE |
Nov 06, 16:00
102.12
-0.02
(-0.02%)
Pre-Market: 20:00
Edwards Lifesciences Cash from Investing (Quarterly) : -256.40M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -256.40M |
| June 30, 2026 | -193.20M |
| March 31, 2026 | -92.80M |
| December 31, 2025 | -198.30M |
| September 30, 2025 | -661.50M |
| June 30, 2025 | -172.10M |
| March 31, 2025 | 85.30M |
| December 31, 2024 | -576.70M |
| September 30, 2024 | 2.702B |
| June 30, 2024 | 124.80M |
| March 31, 2024 | 63.10M |
| December 31, 2023 | 14.10M |
| September 30, 2023 | 89.00M |
| June 30, 2023 | 70.20M |
| March 31, 2023 | 0.50M |
| December 31, 2022 | 94.70M |
| September 30, 2022 | -201.50M |
| June 30, 2022 | 129.60M |
| March 31, 2022 | 229.50M |
| December 31, 2021 | -965.90M |
| September 30, 2021 | -377.40M |
| June 30, 2021 | -329.50M |
| March 31, 2021 | -49.70M |
| December 31, 2020 | -259.90M |
| September 30, 2020 | -126.30M |
| Date | Value |
|---|---|
| June 30, 2020 | -10.20M |
| March 31, 2020 | -134.70M |
| December 31, 2019 | -445.30M |
| September 30, 2019 | -12.70M |
| June 30, 2019 | -88.30M |
| March 31, 2019 | -49.50M |
| December 31, 2018 | 5.70M |
| September 30, 2018 | -254.20M |
| June 30, 2018 | 104.90M |
| March 31, 2018 | 220.30M |
| December 31, 2017 | 49.30M |
| September 30, 2017 | -209.50M |
| June 30, 2017 | -638.20M |
| March 31, 2017 | 151.20M |
| December 31, 2016 | 80.20M |
| September 30, 2016 | 3.90M |
| June 30, 2016 | -343.10M |
| March 31, 2016 | 47.30M |
| December 31, 2015 | 27.30M |
| September 30, 2015 | -175.60M |
| June 30, 2015 | 12.50M |
| March 31, 2015 | -180.30M |
| December 31, 2014 | 112.00M |
| September 30, 2014 | -154.80M |
| June 30, 2014 | -470.40M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 1.898B |
| Stryker Corp. | -187.00M |
| Abbott Laboratories | -385.00M |
| Boston Scientific Corp. | -437.00M |
| Glaukos Corp. | -5.541M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 570.30M |
| Cash from Financing (Quarterly) | -100.80M |
| Free Cash Flow | 1.424B |
| Free Cash Flow Per Share (Quarterly) | 0.8773 |
| Free Cash Flow to Equity (Quarterly) | 506.60M |
| Free Cash Flow to Firm (Quarterly) | 506.70M |
| Free Cash Flow Yield | 2.41% |